AKR7A3 Blocking Peptide (N-Term)
€363.00
In stock
SKU
AC-BP21993a
Background:
Can reduce the dialdehyde protein-binding form of aflatoxin B1 (AFB1) to the non-binding AFB1 dialcohol. May be involved in protection of liver against the toxic and carcinogenic effects of AFB1, a potent hepatocarcinogen.
Other Names:
Aflatoxin B1 aldehyde reductase member 3, 1.-.-.-, AFB1 aldehyde reductase 2, AFB1-AR 2, AKR7A3, AFAR2
Target/Specificity:
The synthetic peptide sequence is selected from aa 33-44 of HUMAN AKR7A3
Gene Name: AKR7A3
Gene ID: 22977
Primary Accession: O95154
Other Accession: Q8NHP1
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Can reduce the dialdehyde protein-binding form of aflatoxin B1 (AFB1) to the non-binding AFB1 dialcohol. May be involved in protection of liver against the toxic and carcinogenic effects of AFB1, a potent hepatocarcinogen.
Other Names:
Aflatoxin B1 aldehyde reductase member 3, 1.-.-.-, AFB1 aldehyde reductase 2, AFB1-AR 2, AKR7A3, AFAR2
Target/Specificity:
The synthetic peptide sequence is selected from aa 33-44 of HUMAN AKR7A3
Gene Name: AKR7A3
Gene ID: 22977
Primary Accession: O95154
Other Accession: Q8NHP1
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review